文献速递乳腺癌放疗放疗物理与技术

放射性相关血管肉瘤的临床与预后多中心分析

Clinical and prognostic insights into radiation-associated angiosarcoma: a multi-institutional analysis.
PubMed 文献 · Radiat Oncol · 2026-08-19

德国四家转诊中心71例病理确诊的原发或复发放射性相关血管肉瘤(RAAS)患者中,90%有乳腺癌放疗史,中位潜伏期7年,中位总生存41.7个月,中位无进展生存9.5个月;肿瘤较大和诊断时转移与更差总生存相关。

要点

  • RAAS多发生于乳腺癌放疗后,中位潜伏期7年。
  • 中位OS 41.7个月,中位PFS 9.5个月。
  • 肿瘤较大及诊断时转移与更差OS相关。

核心结论

  • RAAS是放疗后数年发生的侵袭性、易复发恶性肿瘤,肿瘤较大和诊断时转移与更差OS相关。

研究设计与样本

  • 德国四家转诊中心的多中心回顾性队列研究,纳入71例病理确诊的原发或复发RAAS患者。

主要发现

  • 71例患者中97.2%为女性,中位年龄69岁,90%有乳腺癌放疗史。
  • RAAS平均潜伏期7年,中位放疗剂量59.4 Gy。
  • 中位随访13.0个月,中位OS 41.7个月,1年和2年OS率分别为82.9%和61.7%。
  • 中位PFS 9.5个月,1年和2年PFS率分别为43.7%和27.1%。
  • 较大肿瘤(HR 1.09,p=0.032)和诊断时转移(HR 2.98,p=0.003)与更差OS相关。

临床怎么用

  • 对乳腺癌放疗后出现皮肤或软组织病变者应警惕RAAS,尽早诊断以争取较小肿瘤负荷。
  • 诊断时需评估转移情况,因其与更差OS相关。

局限性

  • 回顾性多中心设计,样本量71例,随访时间有限,需多中心和转化研究进一步明确疾病生物学与风险因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate oncological outcomes and prognostic factors in patients with radiation-associated angiosarcoma (RAAS) treated at referral centers. METHODS: We conducted a multi-institutional retrospective cohort study of patients with histopathologically confirmed primary or recurrent RAAS treated at four referral centers in Germany. Endpoints were overall survival (OS) and progression-free survival (PFS), estimated using the Kaplan-Meier method. Prognostic factors were assessed using multivariable Cox regression. RESULTS: Among 71 patients (97.2% female; median age 69 years), 90% had a history of breast cancer treated with radiotherapy (RT). RAAS developed after a mean latency of 7 years, with a median RT dose of 59.4 Gy. Over a median follow-up of 13.0 months, OS reached a median of 41.7 months, with 1- and 2-year rates of 82.9% and 61.7%, respectively. Median PFS was 9.5 months, with 1- and 2-year rates of 43.7% and 27.1%. Larger tumor size (HR 1.09, p = 0.032) and metastatic disease at diagnosis (HR 2.98, p = 0.003) were associated with worse OS. CONCLUSIONS: RAAS are aggressive, frequently relapsing malignancies occurring years after RT. Larger tumor size and metastatic presentation are associated with worse OS. Multi-institutional and translational studies are needed to clarify disease biology, refine risk factors, and guide treatment strategies.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Harbrücker M, Hoffmann S, Thiel JT, et al. Clinical and prognostic insights into radiation-associated angiosarcoma: a multi-institutional analysis. Radiat Oncol. 2026. PMID: 42618930. doi:10.1186/s13014-026-02895-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。